Split dosing of artemisinins does not improve antimalarial therapeutic efficacy

Split dosing of artemisinins does not improve antimalarial therapeutic efficacy

It has been suggested recently, based on pharmacokinetic-pharmacodynamic modelling exercises, that twice daily dosing of artemisinins increases malaria parasite killing and so could "dramatically enhance and restore drug effectiveness" in artemisinin resistant P. falciparum malaria infecti...

Bibliografski detalji
Glavni autori:	White, N, Watson, J, Ashley, E
Format:	Journal article
Jezik:	English
Izdano:	Nature Publishing Group 2017

Slični predmeti

The contribution of functional antimalarial immunity to measures of parasite clearance in therapeutic efficacy studies of artemisinin derivatives
od: O'Flaherty, K, i dr.
Izdano: (2019)

Artemisinin antimalarials: preserving the "magic bullet"
od: Maude, R, i dr.
Izdano: (2010)

Artemisinin Antimalarials: Preserving the "Magic Bullet"
od: Maude, R, i dr.
Izdano: (2010)

Artemisinin combination therapy: a good antimalarial, but is the dose right?
od: Paul Garner
Izdano: (2013-12-01)

Artemisinin drugs: novel antimalarial agents.
od: Price, R
Izdano: (2000)

Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
od: Das, D, i dr.
Izdano: (2013)

Artemisinins and synthetic peroxides as highly efficient antimalarials
od: Dejan Milos Opsenica, i dr.
Izdano: (2012-12-01)

Immunochemical Analysis of the Antimalarial Drugs Artemisinin and Artesunate
od: Hiroyuki Tanaka, i dr.
Izdano: (2012-11-01)

Monitoring the Efficacy and Safety of Artemisinin-Based Combination Therapies: A Review and Network Meta-analysis of Antimalarial Therapeutic Efficacy Trials in Cameroon
od: Solange Whegang Youdom, i dr.
Izdano: (2019-01-01)

STARTER checklist for antimalarial therapeutic efficacy reporting
od: Mateusz M. Plucinski, i dr.
Izdano: (2022-06-01)

Transmission of artemisinin-resistant malaria parasites to mosquitoes under antimalarial drug pressure
od: Witmer, K, i dr.
Izdano: (2020)

Loading dose in antimalarial prophylaxis.
od: White, N
Izdano: (1985)

Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania
od: Mandike Renata, i dr.
Izdano: (2007-11-01)

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
od: Tran Dang Nguyen, i dr.
Izdano: (2023-07-01)

Antimalarial Mechanisms and Resistance Status of Artemisinin and Its Derivatives
od: Dan Zheng, i dr.
Izdano: (2024-09-01)

RELATION OF ELECTRONIC STRUCTURES WITH THEIR ANTIMALARIAL ACTIVITIES ON ARTEMISININ DERIVATIVES
od: Ria Armunanto, i dr.
Izdano: (2010-06-01)

Synthesis and Antimalarial Activity of Novel Dihydro-Artemisinin Derivatives
od: Jian Wang, i dr.
Izdano: (2011-05-01)

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
od: Nguyen, TD, i dr.
Izdano: (2023)

Artemisinin-based combinations.
od: Ashley, E, i dr.
Izdano: (2005)

Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices.
od: Yeung, S, i dr.
Izdano: (2004)

Profiling the Antimalarial Mechanism of Artemisinin by Identifying Crucial Target Proteins
od: Peng Gao, i dr.
Izdano: (2023-12-01)

Synergistic interaction of two antimalarial drugs, artemisinin and concanamycin A
od: Nurul Izzaty Najwa Zahari, i dr.
Izdano: (2023-06-01)

Direct Activation of TRPC3 Channels by the Antimalarial Agent Artemisinin
od: Nicole Urban, i dr.
Izdano: (2020-01-01)

Stable Production of the Antimalarial Drug Artemisinin in the Moss Physcomitrella patens
od: Nur Kusaira Binti Khairul Ikram, i dr.
Izdano: (2017-08-01)

Antimalarial qinghaosu/artemisinin: The therapy worthy of a Nobel Prize
od: Jerapan Krungkrai, i dr.
Izdano: (2016-05-01)

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
od: Permala, J, i dr.
Izdano: (2017)

The assessment of antimalarial drug efficacy.
od: White, N
Izdano: (2002)

Artemisinin-Based Antimalarial Drug Therapy: Molecular Pharmacology and Evolving Resistance
od: Laura E. Heller, i dr.
Izdano: (2019-06-01)

Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Medecins Sans Frontieres.
od: Guthmann, J, i dr.
Izdano: (2008)

Post-marketing assessment of content and efficacy of preservatives in artemisinin-derived antimalarial dry suspensions for paediatric use
od: Plaizier-Vercammen Jacqueline, i dr.
Izdano: (2007-01-01)

Antimalarial dosing regimens and drug resistance.
od: Barnes, K, i dr.
Izdano: (2008)

Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization.
od: White, N
Izdano: (2013)

A SAR and QSAR Study of New Artemisinin Compounds with Antimalarial Activity
od: Cleydson Breno R. Santos, i dr.
Izdano: (2013-12-01)

Efficacies and ADME properties of redox active methylene blue and phenoxazine analogues for use in new antimalarial triple drug combinations with amino-artemisinins
od: Daniel J. Watson, i dr.
Izdano: (2024-01-01)

Methaemoglobinaemia and the radical curative efficacy of 8-aminoquinoline antimalarials
od: White, NJ, i dr.
Izdano: (2022)

Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum.
od: Mcgready, R, i dr.
Izdano: (2001)

Current Antimalarial Therapies and Advances in the Development of Semi-Synthetic Artemisinin Derivatives
od: LUIZ C.S. PINHEIRO, i dr.

Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières.
od: Jean-Paul Guthmann, i dr.
Izdano: (2008-08-01)

Artemisinin antimalarials in pregnancy: A prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum
od: McGready, R, i dr.
Izdano: (2001)

World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
od: Price, R, i dr.
Izdano: (2007)